Subtopic Deep Dive
Homocysteine and Cardiovascular Disease Risk
Research Guide
What is Homocysteine and Cardiovascular Disease Risk?
Homocysteine and Cardiovascular Disease Risk examines plasma homocysteine as a potential causal factor for atherosclerosis, thrombosis, stroke, and ischemic heart disease, tested via cohort studies, intervention trials with B-vitamins, and Mendelian randomization.
Elevated homocysteine associates with cardiovascular events in observational data, but randomized trials of B-vitamin supplementation show no risk reduction. Key meta-analyses include Homocysteine Studies Collaboration (2002, 2050 citations) and Wald et al. (2002, 1932 citations). Over 10 major papers from 1997-2015, with 1000+ citations each, debate causality.
Why It Matters
Elevated homocysteine affects CVD risk assessment for millions, influencing guidelines like Krauss et al. (2000, AHA Dietary Guidelines, 1455 citations). Intervention trials such as Lonn (2006, 1700 citations) and Bønaa et al. (2006, 1437 citations) found no benefit from folic acid and B-vitamins, shifting focus from supplementation to other factors. Nygård et al. (1997, 1769 citations) linked high homocysteine to mortality in coronary patients, informing personalized risk models. Ganguly and Alam (2015, 1016 citations) summarized mechanisms, aiding prevention strategies.
Key Research Challenges
Causality Determination
Observational links exist, but RCTs fail to confirm causality. Homocysteine Studies Collaboration (2002) found modest prediction; Wald et al. (2002) used meta-analysis for causal estimates. Mendelian randomization via MTHFR variants remains underused (Botto and Yang, 2000).
Intervention Failures
B-vitamin trials lowered homocysteine but not events. Lonn (2006) and Bønaa et al. (2006) reported no CVD risk reduction, with potential harm suggested. Mechanisms beyond homocysteine likely dominate.
Measurement Standardization
Variability in homocysteine assays affects comparability. Refsum et al. (2004, 1044 citations) provided expert recommendations on determinations. Genetic factors like MTHFR complicate levels (Botto and Yang, 2000).
Essential Papers
Homocysteine and Risk of Ischemic Heart Disease and Stroke
Homocysteine Studies Collaboration · 2002 · JAMA · 2.0K citations
This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations. Studies of the impact on dis...
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
David S Wald, Malcolm Law, Joan K Morris · 2002 · BMJ · 1.9K citations
Abstract Objective: To assess whether the association of serum homocysteine concentration with ischaemic heart disease, deep vein thrombosis and pulmonary embolism, and stroke is causal and, if so,...
Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease
Ottar Nygård, Jan Erik Nordrehaug, Helga Refsum et al. · 1997 · New England Journal of Medicine · 1.8K citations
Plasma total homocysteine levels are a strong predictor of mortality in patients with angiographically confirmed coronary artery disease.
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
Eva Lonn · 2006 · New England Journal of Medicine · 1.7K citations
Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current C...
AHA Dietary Guidelines
Ronald M. Krauss, Robert H. Eckel, Barbara V. Howard et al. · 2000 · Circulation · 1.5K citations
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Kaare Harald Bønaa, Inger Njølstad, Per Magne Ueland et al. · 2006 · New England Journal of Medicine · 1.4K citations
Treatment with B vitamins did not lower the risk of recurrent cardiovascular disease after acute myocardial infarction. A harmful effect from combined B vitamin treatment was suggested. Such treatm...
5, 10-Methylenetetrahydrofolate Reductase Gene Variants and Congenital Anomalies: A HuGE Review
Lorenzo D. Botto, Quanhe Yang · 2000 · American Journal of Epidemiology · 1.0K citations
The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism. The MTHFR gene is located on chromosome 1 (1p36.3), and two common alleles, the C677T (thermolabile) al...
Reading Guide
Foundational Papers
Start with Homocysteine Studies Collaboration (2002) for observational meta-analysis baseline, Nygård et al. (1997) for mortality prediction in CAD patients, then Wald et al. (2002) for causality assessment.
Recent Advances
Study Ganguly and Alam (2015) for mechanism summary; Refsum et al. (2004) for measurement standards; Botto and Yang (2000) for genetic variants.
Core Methods
Core techniques: prospective cohort tracking (Nygård 1997), meta-regression for causality (Wald 2002), double-blind RCTs with folic acid/B-vitamins (Lonn 2006), MTHFR genotyping (Botto 2000).
How PapersFlow Helps You Research Homocysteine and Cardiovascular Disease Risk
Discover & Search
Research Agent uses searchPapers and citationGraph to map 2000+ citation networks from Homocysteine Studies Collaboration (2002), revealing Wald et al. (2002) as a key node. exaSearch finds Mendelian randomization papers; findSimilarPapers expands to Nygård et al. (1997) variants.
Analyze & Verify
Analysis Agent applies readPaperContent to extract trial data from Lonn (2006), then runPythonAnalysis for meta-analysis pooling of hazard ratios with pandas/NumPy. verifyResponse (CoVe) and GRADE grading assess evidence quality, verifying observational bias vs. RCT null results.
Synthesize & Write
Synthesis Agent detects gaps in causality post-RCTs, flags contradictions between Nygård (1997) and Bønaa (2006). Writing Agent uses latexEditText, latexSyncCitations for review drafts, latexCompile for figures, exportMermaid for trial flowcharts.
Use Cases
"Run meta-analysis on homocysteine mortality data from coronary cohorts"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas forest plot of HRs from Nygård 1997 + similar) → statistical output with p-values and CI.
"Draft LaTeX review of B-vitamin trials for CVD"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Lonn 2006, Bønaa 2006) → latexCompile → PDF with synced bibliography.
"Find code for homocysteine Mendelian randomization simulations"
Research Agent → paperExtractUrls (Botto 2000) → Code Discovery → paperFindGithubRepo → githubRepoInspect → R scripts for MTHFR variant analysis.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (50+ homocysteine papers) → citationGraph → GRADE grading → structured report on causality evidence. DeepScan applies 7-step analysis with CoVe checkpoints to verify Wald (2002) causal claims against Lonn (2006) trials. Theorizer generates hypotheses on residual homocysteine effects post-fortification.
Frequently Asked Questions
What defines homocysteine-CVD risk research?
It evaluates plasma homocysteine as a risk factor for atherosclerosis, thrombosis, stroke via cohorts, B-vitamin trials, and Mendelian randomization.
What are key methods used?
Methods include prospective cohorts (Nygård 1997), meta-analyses of observational data (Homocysteine Studies Collaboration 2002), RCTs (Lonn 2006), and MTHFR genetic analysis (Botto 2000).
What are seminal papers?
Top papers: Homocysteine Studies Collaboration (2002, 2050 citations), Wald et al. (2002, 1932 citations), Nygård et al. (1997, 1769 citations).
What open problems persist?
Causality unresolved despite RCTs; role of MTHFR variants in populations; post-fortification effects need re-evaluation.
Research Folate and B Vitamins Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Homocysteine and Cardiovascular Disease Risk with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Folate and B Vitamins Research Research Guide